Inventor · disambiguated record
Scott W. Lowe
Also filed as: LOWE SCOTT · LOWE SCOTT W · LOWE SCOTT WILLIAM
16 granted patents·32 pending applications·104 citations·filing 1996–2023
93Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER18COLD SPRING HARBOR LAB16LOWE SCOTT W3DANA FARBER CANCER INST INC2ZENDER LARS2
Top patents by PatentIndex Score
48 records- 0188US9815849B2Compositions and methods for treating leukemiaDANA FARBER CANCER INST INC·Filed 2013·Granted Nov 14, 2017·14 cites·13 claims
- 0288US8426675B2Methods for producing microRNAsDICKINS ROSS·Filed 2011·Granted Apr 23, 2013·14 cites·7 claims
- 0382US10676484B2Compositions and methods for treating leukemiaDANA FARBER CANCER INST INC·Filed 2017·Granted Jun 9, 2020·2 cites·20 claims
- 0482US8901288B2High throughput methods for functionally determining RNA interference efficiencyFELLMANN CHRISTOF·Filed 2008·Granted Dec 2, 2014·6 cites·36 claims
- 0582US7993925B2Methods for producing microRNAsCOLD SPRING HARBOR LAB·Filed 2008·Granted Aug 9, 2011·4 cites·11 claims
- 0678US8399248B2Methods of using MIR34 as a biomarker for TP53 functional statusCLEARY MICHELE A·Filed 2008·Granted Mar 19, 2013·5 cites·14 claims
- 0776US8895526B2Identification of RNAI targets and use of RNAI for rational therapy of chemotherapy-resistant leukemia and other cancersSTILLMAN BRUCE·Filed 2010·Granted Nov 25, 2014·10 cites·7 claims
- 0873US8137907B2Orthotopic and genetically tractable non-human animal model for liver cancer and the uses thereofZENDER LARS·Filed 2008·Granted Mar 20, 2012·6 cites·18 claims
- 0970US10383873B2Method and kits for identifying of CDK9 inhibitors for the treatment of cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Aug 20, 2019·1 cites·6 claims
- 1067US2024123069A1Antigen recognizing receptors targeting upar and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 1166US2025213721A1Compositions including ifne and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 1266US2024117066A1Anti-upar antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 1365US11633401B2Combination therapy with MEK inhibitor and CDK4/6 inhibitor to treat pancreatic cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Apr 25, 2023·0 cites·11 claims
- 1465US2024108628A1Combination therapy with mek inhibitor and cdk4/6 inhibitor to treat pancreatic cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 1565US2024131070A1Antigen recognizing receptors targeting upar and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 1665US2024254253A1ANTI-uPAR ANTIBODIES AND USES THEREOFMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 1763US2010186097A1Cell-based rna interference and related methods and compositionsCOLD SPRING HARBOR LAB·Filed 2009·Application pending·0 cites
- 1861US2020054640A1Method and kits for identifying of cdk9 inhibitors for the treatment of cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 1960US2024189358A1Car-t cells targeting upar and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 2059US2008226553A1Cell-Based Rna Interference and Related Methods and CompositionsCOLD SPRING HARBOR LAB·Filed 2003·Application pending·0 cites
- 2158US7794941B2Role of FGF-20 in cancer diagnosis and treatmentCOLD SPRING HARBOR LAB·Filed 2007·Granted Sep 14, 2010·0 cites·12 claims
- 2257US6583333B1Lymphoma-susceptible transgenic mice and methods for studying drug sensitivity of lymphomasCOLD SPRING HARBOR LAB·Filed 1998·Granted Jun 24, 2003·17 cites·10 claims
- 2357US5897992ACell-free assay using oncogene-induced apoptosis in drug-resistant cellsCOLD SPRING HARBOR LAB·Filed 1996·Granted Apr 27, 1999·19 cites·10 claims
- 2457US2015057164A1High throughput methods for functionally determining rna interference efficiencyCOLD SPRING HARBOR LAB·Filed 2014·Application pending·0 cites
- 2556US2007044164A1Methods for producing microRNAsCOLD SPRING HARBOR LAB·Filed 2006·Application pending·0 cites
- 2653US2015283101A1Identification of rnai targets and use of rnai for rational therapy of chemotherapy-resistant leukemia and other cancersCOLD SPRING HARBOR LAB·Filed 2014·Application pending·0 cites
- 2751US2022193109A1Compositions and methods for treating ras-mutant cancersMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 2851US2021220471A1Methods of using pharmacologic inhibitors of type 2 cytokine signaling to treat or prevent pancreatic cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 2951US2010273660A1ONCOGENOMICS-BASED RNAi SCREEN AND USE THEREOF TO IDENTIFY NOVEL TUMOR SUPPRESSORSCOLD SPRING HARBOR LAB·Filed 2009·Application pending·0 cites
- 3050US2011035814A1Cooperating oncogenes in cancerCOLD SPRING HARBOR LAB·Filed 2007·Application pending·0 cites
- 3149US2010297010A1Tumor suppressor gene screening using rna interference libraries and method of treatmentBRIC ANKA·Filed 2008·Application pending·0 cites
- 3249US2004048821A1Enhancement of drug cytotoxicity in tumor cells containing mutant Rb geneCOLD SPRING HARBOR LAB·Filed 2003·Application pending·0 cites
- 3349US2009217404A1Cell-based RNA interference and related methods and compositionsLOWE SCOTT W·Filed 2008·Application pending·0 cites
- 3447US2022135982A1Compositions for suppressing trim28 and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 3547US2009022685A1Orthotopic, controllable, and genetically tractable non-human animal model for cancerLOWE SCOTT W·Filed 2007·Application pending·0 cites
- 3645US2008242622A1Identification of genetic alterations that modulate drug sensitivity in cancer treatmentsCOLD SPRING HARBOR LAB·Filed 2008·Application pending·0 cites
- 3745US2022280538A1Methods of treating p53 mutant cancers using ogdh inhibitorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 3845US2022098320A1Senolytic car-t cells targeting upar, a cell surface and secreted senescence biomarkerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 3943US2010310504A1Methods for treating fibrosis by modulating cellular senescenceLOWE SCOTT W·Filed 2008·Application pending·0 cites
- 4042US10792284B2Synergistic cancer treatmentMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Oct 6, 2020·0 cites·10 claims
- 4142US2019338290A1Treatment of sarcomaMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Application pending·0 cites
- 4241US2009186839A1Model for studying the role of genes in chemoresistanceCOLD SPRING HARBOR LAB·Filed 2007·Application pending·0 cites
- 4339US2006294604A1Model for studying the role of genes in tumor resistance to chemotherapyFRIDMAN JORDAN S·Filed 2004·Application pending·0 cites
- 4437US2020323898A1Compositions and methods for treating acute myeloid leukemiaMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Application pending·0 cites
- 4537US2006162000A1Development and use of a new orthotopic, genetically tractable non-human animal model for liver cancerZENDER LARS·Filed 2006·Application pending·0 cites
- 4633US6555330B1Oncogene-induced apoptosis in drug-resistant cellsCOLD SPRING HARBOR LAB·Filed 1999·Granted Apr 29, 2003·4 cites·17 claims
- 4730US6670139B1Cell-free assay using oncogene-induced apoptosis to identify inhibitors of apoptosis in drug-resistant cellsCOLD SPRING HARBOR LAB·Filed 1999·Granted Dec 30, 2003·2 cites·20 claims
- 4824US2017038384A1Treatment of tumors expressing mutant p53SLOAN-KETTERING INST FOR CANCER RES·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →